Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. J. Moghaddam, P. Barta, Z. Ammar-Aouchiche, N. Torres Garza, T. T. Vo, R. A. Newman, B. B. Aggarwal, M. J. Tuvim, R. Lotan, B. F. Dickey (Houston, United States Of America; Monterrey, Mexico). Curcumin inhibits COPD-like airway inflammation and lung cancer promotion in mice. Eur Respir J 2009; 34: Suppl. 53, 4477

Member's Comments

No comment yet.

Related content which might interest you: Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012 Effect of nintedanib on silica-induced lung inflammation and fibrosis in mice Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside Year: 2012 Dexamethasone reduces lung inflammation induced by alveolar stretch in mice Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury Year: 2011 Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy Source: Eur Respir J 2013; 42: 350-361 Year: 2013 Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy Source: Eur Respir J 2014; 43: 1208-1211 Year: 2014 Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy Source: Eur Respir J 2014; 43: 1211-1212 Year: 2014 Simvastatin attenuates cigarette-smoke- induced emphysema and promotion of alveolar epithelial cell proliferation in rats Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 P2RX4 signalling enhances acute cigarette smoke-induced lung inflammation and chronic lung emphysema development Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019 Enhanced lung inflammatory response to intratracheal CpG-ODN in mice with bleomycin-induced lung fibrosis Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases Year: 2011 Stem cell therapy attenuates airway and lung parenchyma remodeling in a murine model of chronic allergic asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 LPS accelerates cigarette smoke-induced deterioration in respiratory function and airway inflammation in mice Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence Year: 2007 The inhibition of caspase-11 could prevent lung cancer in smoking mice Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021 Effects of autophagy on LPS-induced lung inflammation and acute lung injury (ALI) in vitro and in vivo Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018 Osteopontin promotes urethane-induced airway epithelial carcinogenesis Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009 PAR-2 agonists induce TGF-beta and EMT leading to lung fibrosis Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Increased expression of Lipocalin2 suppresses allergen-induced airway disease in mice Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008 The role of chronic inflammation in mouse lung tumourigenesis Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection Year: 2005 Transgenic mice expressing a surfactant protein-B-urokinase-fusion protein in the distal respiratory epithelium show an attenuated fibrotic response to bleomycin-induced lung injury Source: Annual Congress 2005 - In vivo - approaches to lung injury Year: 2005 TD-0903, an inhaled JAK inhibitor in development for COVID-19, blocks ARDS-relevant hyperinflammation and lung injury in primary human immune and airway epithelial cells Source: Virtual Congress 2021 – Emerging respiratory diseases: state-of-the-art studies of SARS-CoV-2 infection Year: 2021 The PD-1 immune checkpoint promotes lung damage in murine models of COPD-like inflammation Source: International Congress 2019 – Injury and repair: less is more Year: 2019